During the past decade, Istanbul University Cerrahpasa Medical Faculty conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 23 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 13 clinical trials were completed. i.e. 32.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istanbul University Cerrahpasa Medical Faculty" #1 sponsor was "Istanbul University" with 16 trials, followed by "Janssen Research & Development, LLC" with 15 trials sponsored, "Hoffmann-La Roche" with 14 trials sponsored, "Celgene" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul University Cerrahpasa Medical Faculty" #1 collaborator was "Ayse Cigdem Tutuncu" with 3 trials as a collaborator, "Istanbul University" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator and "Kaya, Guner, M.D." with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Istanbul University Cerrahpasa Medical Faculty" are "Crohn Disease" (6 trials), "Breast Cancer" (5 trials), "COVID-19" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Istanbul University Cerrahpasa Medical Faculty" in a lesser frequency.

Most popular intervention types in "Istanbul University Cerrahpasa Medical Faculty" are "Drug" (87 trials), "Other" (15 trials), "Biological" (10 trials), "Procedure" (5 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Carboplatin" (7 trials), "Cisplatin" (7 trials), "Guselkumab" (6 trials) and "Pemetrexed" (6 trials). Other intervention names were less common.

The vast majority of trials in "Istanbul University Cerrahpasa Medical Faculty" are 114 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Istanbul University Cerrahpasa Medical Faculty". undefined are not yet recruiting, 34 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Istanbul University Cerrahpasa Medical Faculty, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Istanbul University Cerrahpasa Medical Faculty, 5 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".

Istanbul University Cerrahpasa Medical Faculty has several departments that took part in Clinical trials: "Inonu University Medical Faculty" - 11 trials, "Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation" - 9 trials, "Ufuk University Faculty of Medicine Hospital" - 6 trials, "Ankara Yıldırım Beyazıt University Faculty of Dentistry" - 3 trials, "Ankara Yıldırım Beyazıt University, Institute of Health Sciences, Department of Physiotherapy and Rehabilitation" - 3 trials, "Yildirim Beyazit University Medical Faculty Ankara Atatürk Research and Training Hospital" - 3 trials, "Istanbul University, Cerrahpasa Medical Faculty; Pediatrics Department" - 2 trials